1-7 of 7
Jean-Michel Pignon, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Prognostication of Molecular Relapses after Dasatinib or Nilotinib Discontinuation in Chronic Myeloid Leukemia (CML): A FI-LMC STOP 2G-TKI Study Update

Delphine Rea, MD, Franck E Nicolini, MDPhD, Michel Tulliez, MD, Philippe Rousselot, MDPhD, Martine Gardembas, MD, Gabriel Etienne, MD PhD, Francois Guilhot, MD, Joelle Guilhot, PhD, Agnès Guerci, MD PhD, Martine Escoffre-Barbe, MD, Laurence Legros, MD PhD, Bruno Villemagne, MD, Gaëlle Guillerm, MD, Marie-Pierre Noel, MD, Valerie Coiteux, MD, Jean-Michel Pignon, MD, Francois-Xavier Mahon, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 30.
https://doi.org/10.1182/blood-2019-124408
Published: 2019
Journal Articles

Efficacy of the Ribvd Regimen in High Risk Mantle Cell Lymphoma Patients As Defined By the Mipic Prognostic Score: Identification of KI67, LDH and Performance Status As Most Important Prognostic Factors (PF). a French Lysa Group Study

Remy Gressin, MD, Anne Moreau, MD, Nicolas Daguindau, MD, Adrien Tempescul, MD, Sylvain Carras, MD, Jean-Michel Pignon, MD, Guillaume Cartron, MD PhD, Roch Houot, MD PhD, Caroline Dartigeas, MD, Anne Schmitt, MD, Krimo Bouabdallah, MD, Jehan Dupuis, MD, Christiane Mounier, MD, Lionel Karlin, MD, Fabrice Jardin, MD PhD, Luc Mathieu Fornecker, MD PhD, Selim Corm, MD, Joel Fleury, MD, Barbara Burroni, MD, Loic Ysebaert, MD PhD, Steven Le Gouill, MD PhD
Journal: Blood
Blood (2016) 128 (22): 5302.
https://doi.org/10.1182/blood.V128.22.5302.5302
Published: 2016
Journal Articles

Personalized Daily Doses of Imatinib By Therapeutic Drug Monitoring Increase the Rates of Molecular Responses in Patients with Chronic Myeloid Leukemia. Final Results of the Randomized OPTIM Imatinib Study

Philippe Rousselot, MD PhD, Hyacinthe Johnson-Ansah, MD, Françoise Huguet, MD, Laurence Legros, MD, Martine Escoffre-Barbe, Martine Gardembas, MD, Pascale Cony-Makhoul, MD, Valérie Coiteux, MD, Laurent Sutton, MD, Wajed Abarah, MD, Camille Pouaty, MD, Jean Michel Pignon, MD, Bachra Choufi, MD, Sorin Visanica, MD, Bénédicte Deau, MD, Stephane Bouchet, MDPhD, Francois Guilhot, MD, Francois-Xavier Mahon, MD PhD Professor, Laure Morisset, Jean-Michel Cayuela, Benjamin Maneglier, MD
Journal: Blood
Blood (2015) 126 (23): 133.
https://doi.org/10.1182/blood.V126.23.133.133
Published: 2015
Journal Articles

Dasatinib or Nilotinib Discontinuation in Chronic Phase (CP)-Chronic Myeloid Leukemia (CML) Patients (pts) with Durably Undetectable BCR-ABL Transcripts: Interim Analysis of the STOP 2G-TKI Study with a Minimum Follow-up of 12 Months – on Behalf of the French CML Group Filmc

Delphine Rea, MD PhD, Franck E. Nicolini, MD PhD, Michel Tulliez, MD, Philippe Rousselot, MD, Francois Guilhot, MD, Martine Gardembas, MD, Agnès Guerci, MD, Valérie Coiteux, MD, Laurence Legros, MD PhD, Gaelle Guillerm, MD, Jean Michel Pignon, MD, Stephane Giraudier, MD PhD, Gabriel Etienne, Bruno Villemagne, MD, Martine Escoffre, MD, Aude Charbonnier, MD PhD, Francois-Xavier Mahon, MD PhD
Journal: Blood
Blood (2014) 124 (21): 811.
https://doi.org/10.1182/blood.V124.21.811.811
Published: 2014
Journal Articles

Frontline Therapy with the Ribvd Regimen Elicits High Clinical and Molecular Response Rates and Long PFS in Elderly Patients Mantle Cell Lymphoma (MCL); Final Results of a Prospective Phase II Trial By the Lysa Group

Remy Gressin, MD, Mary Callanan, MD PhD, Nicolas Daguindau, MD, Adrian Tempescul, MD, Sylvain Carras, Marie Pierre Moles, MD, Guillaume Cartron, MD, Roch Houot, MD PhD, Caroline Dartigeas, MD, Jean Michel Pignon, MD, Selim Corm, MD PhD, Anne Banos, MD, Christiane Mounier, MD, Jehan Dupuis, MD, Margareth Macro, MD, Joel Fleury, MD, Fabrice Jardin, MD PhD, Lionel Karlin, Pierre Feugier, MD PhD, Luc Matthieu Fornecker, MD, Cecile Chabrot, Veronique Dorvaux, MD, Krimo Bouabdallah, MD, Sandy Amorin, MD, Reda Garidi, MD, Laurent Voillat, MD, Bertrand Joly, MD, Katell Le Dû, Nadine Morineau, Hacene Zerazhi, MD, Jean Fontan, Yazid Arkam, MD, Magda Alexis, MD, Vincent Delwail, MD, Jean Pierre Vilque, MD, Loic Ysebaert, MDPhD, Steven Le Gouill, MD PhD, Ghandi Damaj, MD
Journal: Blood
Blood (2014) 124 (21): 148.
https://doi.org/10.1182/blood.V124.21.148.148
Published: 2014
Journal Articles

Prognostic Of IgD Myeloma In The Era Of Novel Agents

Luca Inchiappa, MD, Charles Herbaux, MD, Stéphanie Guidez, MD, Guillemette Fouquet, MD, David Beauvais, MD, Zoé Van de Wyngaert, MD, Helene Demarquette, MD, Sarah Bonnet, MD, Bénédicte Hivert, MD, Mathieu Wemeau, MD, Nathalie Cambier, MD, Christian Rose, MD, Maxime Bemba, MD, Jean Michel Pignon, MD, Thierry Facon, MD, Bruno Royer, MD, Murielle Roussel, MD, Denis Caillot, MD, Marc Wetterwald, MD, PhD, Xavier Leleu, MD, PhD
Journal: Blood
Blood (2013) 122 (21): 1880.
https://doi.org/10.1182/blood.V122.21.1880.1880
Published: 2013
Journal Articles

The Ribvd Regimen (Rituximab IV, Bendamustine IV, Velcade SC, Dexamethasone IV) Offers a High Complete Response Rate In Elderly Patients With Untreated Mantle Cell Lymphoma. Preliminary Results Of The Lysa Trial “Lymphome Du Manteau 2010 SA”

Remy Gressin, MD, Mary Callanan, MD, PhD, Nicolas Daguindau, MD, Adrian Tempescul, MD, Sylvain Carras, Guillaume Cartron, MD, PhD, Anne Schmitt, MD, Roch Houot, MD, PhD, Caroline Dartigeas, MD, Jean Michel Pignon, MD, Selim Corm, MD, PhD, Anne Banos, MD, Jehan Dupuis, MD, Christiane Mounier, MD, Margareth Macro, MD, Joel Fleury, MD, Fabrice Jardin, MD, PhD, Lionel Kardin, MD, Gandhi Damaj, MD, Pierre Feugier, MD, PhD, luc Matthieu Fornacker, MD, Cecile molucon Chabrot, MD, Veronique Dorvaux, MD, Krimo Bouabdallah, MD, Sandy Amorin, MD, Reda Garidi, MD, Laurent Voillat, MD, Bertrand Joly, MD, Philippe Solal-Céligny, MD, Nadine Morineau, MD, Marie Pierre Moles, MD, Hacene Zerazhi, MD, Jean Fontan, MD, Yazid Arkam, MD, Magda Alexis, MD, Vincent Delwail, MD, Jean Pierre Vilque, MD, Loic Ysebaert, MD PhD, Steven Le Gouill, MD, PhD
Journal: Blood
Blood (2013) 122 (21): 370.
https://doi.org/10.1182/blood.V122.21.370.370
Published: 2013